10-102138904-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_015062.5(PPRC1):c.515G>A(p.Arg172Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015062.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPRC1 | NM_015062.5 | c.515G>A | p.Arg172Gln | missense_variant | 4/14 | ENST00000278070.7 | NP_055877.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPRC1 | ENST00000278070.7 | c.515G>A | p.Arg172Gln | missense_variant | 4/14 | 1 | NM_015062.5 | ENSP00000278070 | P2 | |
PPRC1 | ENST00000413464.6 | c.515G>A | p.Arg172Gln | missense_variant | 4/12 | 2 | ENSP00000399743 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251464Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135914
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727240
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.515G>A (p.R172Q) alteration is located in exon 4 (coding exon 4) of the PPRC1 gene. This alteration results from a G to A substitution at nucleotide position 515, causing the arginine (R) at amino acid position 172 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at